Genetic Testing Market Size 2025-2029
The genetic testing market size is forecast to increase by USD 11.06 billion at a CAGR of 15.2% between 2024 and 2029.
- The market is experiencing significant growth, driven primarily by the rising prevalence of genetic diseases and disorders worldwide. According to various estimates, genetic disorders affect approximately 1 in 20 people, making it an increasingly pressing health concern. This trend is further fueled by advancements in next-generation sequencing technologies, which have made genetic testing more accessible, affordable, and accurate than ever before. However, the market's growth is not without challenges. Varying regulations on genetic testing and research globally present significant barriers to entry for new players and limit market expansion in certain regions.
- Additionally, the market is witnessing the emergence of consumer awareness, digital health, and artificial intelligence (AI) in genetic testing. Companies seeking to capitalize on market opportunities must navigate these regulatory complexities while staying abreast of technological advancements and evolving consumer preferences. Effective strategic planning and operational agility will be essential for success in this dynamic and rapidly evolving market.
What will be the Size of the Genetic Testing Market during the forecast period?
Request Free Sample
-
The market in the United States is experiencing significant growth due to the increasing demand for personalized healthcare and advancements in technology. The integration of big data and cloud computing in genetic research is facilitating the analysis of vast amounts of genetic information. Moreover, the market is witnessing a wave in areas such as animal genetics, forensic genetics, and plant genetics. The application of genetic testing in cardiovascular gene panels, neurological gene panels, and cancer gene panels is gaining traction, leading to improved disease diagnosis and treatment.
Genetic diversity, population genomics, and genetic epidemiology are also driving market growth. Technological advancements, such as gene silencing, SNP arrays, gene knockouts, and genome editing, are revolutionizing the field. Ethical guidelines and data privacy regulations are essential considerations in this market, ensuring the protection of individuals' genetic information. Additionally, the market is witnessing the emergence of consumer awareness, digital health, and artificial intelligence (AI) in genetic testing. These trends are transforming the industry, enabling more accessible and accurate genetic testing services.
Furthermore, clinical trials, genetic counseling services, and agricultural biotechnology are crucial components of the market's ecosystem. Market growth and forecasting indicate a trajectory over the coming years, fueled by continuous innovation and expanding applications across various sectors. Comprehensive market analysis and reports highlight the growing investment in research and development, strategic partnerships, and the increasing role of biotechnology in healthcare and agriculture. Market growth and trends suggest a steady rise in demand for advanced genetic solutions, with personalized medicine at the forefront. Overall, the US market is a dynamic and rapidly evolving industry, driven by technological progress, increasing consumer demand, and a growing awareness of the role of genetics in modern science. Its future direction is characterized by innovation, collaboration, and a commitment to ethical guidelines and data privacy.
How is this Genetic Testing Industry segmented?
The genetic testing industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.
- Product
- Technology
- Molecular testing
- Cytogenetic testing
- Biochemical testing
- Application
- Cancer diagnosis
- Genetic disease diagnosis
- Cardiovascular disease diagnosis
- Others
- End-user
- Hospitals and clinics
- Diagnostic laboratories and centres
- Others
- Geography
- North America
- Europe
- Asia
- China
- India
- Japan
- South Korea
- Rest of World (ROW)
By Product Insights
The equipment segment is estimated to witness significant growth during the forecast period. Genetic testing is a rapidly evolving field that utilizes advanced technologies such as microarray analysis, Genome Sequencing, Exome Sequencing, and liquid biopsy for Disease Risk Assessment, Clinical Interpretation, and Predictive Testing. The market is driven by the increasing demand for Personalized Medicine, precision medicine, and Consumer Adoption. Genetic Engineering, Gene Editing, and Gene Therapy are also significant contributors. The equipment segment includes analyzers, PCR systems, and Next-Generation Sequencing (NGS) machines. The growing workload for high-throughput tests in clinical diagnostic facilities necessitates advanced products like automated analyzers and real-time PCR (RT-PCR) systems. Companies are updating their portfolios with advanced automated analyzers like QIAxcel Advanced System from QIAGEN, ZAG DNA Analyzer Systems from Agilent Technologies, and 3730xl DNA Analyzer from Thermo Fisher Scientific.
This gold-standard equipment offers high-throughput genetic analysis with multiple automation features, reducing human errors during testing. Genetic testing services encompass Clinical Genetic Testing, Prenatal Diagnosis, Hereditary Disease Testing, Cancer Genetics, and newborn screening. Pharmaceutical Companies are increasingly using genetic data interpretation for Drug Development and personalized nutrition. Ethical Considerations, Genetic Information Sharing, Insurance Coverage, and Data Management are critical challenges. data analytics, Data Security, and Genetic Privacy are essential for effective data handling. The market dynamics include the rise of Lifestyle Genetics, Direct-to-Consumer Testing, and Ancestry Testing. Gene Expression Profiling, Genetic Markers, Family History, Tumor Sequencing, Wellness Testing, and Personalized Cancer Treatment are other significant trends.
The regulatory landscape is complex, with ongoing debates on data sharing, patient consent, and data privacy. gene therapy, Rare Disease Testing, and carrier screening are emerging areas. The market costs are decreasing due to advancements in NGS and Data Analytics.
Get a glance at the market report of share of various segments Request Free Sample
The Equipment segment was valued at USD 3.57 billion in 2019 and showed a gradual increase during the forecast period.
Regional Analysis
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market size of various regions, Request Free Sample
The market in North America is experiencing significant growth due to increasing concerns about early disease diagnosis and the rising number of commercial approvals for advanced genetic testing products. Pharmaceutical companies are also increasingly utilizing genetic testing services for pharmacogenomic applications. Chromosome enumeration probes, such as those offered by Abbott Laboratories, are among the advanced products driving market expansion. Additionally, the use of predictive testing, cancer genetics, and prenatal diagnosis is on the rise. Genetic testing reports and laboratory services are essential components of this market, with clinical genetic testing, lifestyle genetics, and direct-to-consumer testing gaining popularity. Data management, genetic data interpretation, and genetic privacy are critical concerns, as is the regulatory landscape.
Gene therapy, gene editing, and gene expression profiling are emerging areas of focus. Personalized nutrition, personalized medicine, and precision medicine are also driving demand. Ethical considerations and genetic screening for rare diseases are essential topics in the market discourse. Genetic testing costs and data analytics are significant factors influencing market dynamics. Data security is another critical concern, as is genetic information sharing among healthcare providers and consumers. Overall, the market in North America is dynamic and evolving, with a focus on innovation and personalized healthcare solutions.
Market Dynamics
Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
What are the key market drivers leading to the rise in the adoption of Genetic Testing Industry?
- The rising prevalence of genetic diseases and disorders is the key driver of the market. Genetic testing is experiencing significant demand in laboratories and hospitals due to the rising prevalence of genetic diseases. According to current research, conditions such as Alzheimer's disease, Down syndrome, cystic fibrosis, and inherited cancers are on the rise. For instance, the Centers for Disease Control and Prevention (CDC) anticipates that the number of Alzheimer's patients will increase to 14 million by 2060. In the UK, approximately 5% of individuals aged 40-65 years have Alzheimer's, and around 5% of those under 40 experience Parkinson's symptoms.
- In Japan, the prevalence of Alzheimer's is projected to swell by 40% by 2028. These statistics underscore the importance of genetic testing in diagnosing and managing these conditions. As a skilled assistant, I can help you gain a better sense of this market dynamic and its implications. Such factors will increase the demand for market analysis and report during the forecast period.
What are the market trends shaping the Genetic Testing Industry?
- Advancements in next-generation sequencing are the upcoming market trend. The Human Genome Project and the emergence of next-generation sequencing (NGS) technologies have significantly impacted the market. NGS has revolutionized genetic research by facilitating large-scale sequencing of the human genome, allowing for the detection of mutations and gene variants associated with various diseases and disorders. This technological advancement has led to a substantial reduction in the cost of sequencing, genomic analysis, and database management, transforming the global genetic testing landscape. NGS enables the identification of genetic variations of intermediate to large size, contributing to a better genomic disorders.
- As a skilled assistant, I am committed to providing accurate and reliable information. The Human Genome Project and NGS technologies have provided market players with valuable resources for organizing and analyzing the complete set of human genomes, leading to significant advancements in genetic research. Such factors will increase the market trends and analysis during the forecast period.
What challenges does the Genetic Testing Industry face during its growth?
- Varying regulations on genetic testing and research globally are a key challenge affecting the industry's growth. The market is subject to various regulatory standards and compliance, making it a complex landscape for market participants. These regulations, enforced by authorities such as the US FDA, EMEA, EAEMP, ATGA, WHO, ISO, and CFDA, prioritize the accuracy, safety, and reliability of genetic testing procedures due to their direct impact on healthcare decision-making for critical health conditions.
- Ensuring compliance with these regulations is essential for market players, as the consequences of inaccurate or unreliable test results can be significant. The intricacy of these regulations adds to the market's challenges, requiring substantial resources and expertise from companies to navigate and adhere to them. Such factors will hinder the market during the forecast period.
Exclusive Customer Landscape
The genetic testing market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the genetic testing market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Key Companies & Market Insights
Companies are implementing various strategies, such as strategic alliances, genetic testing market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Abbott Laboratories - The company offers genetic testing, such as Vysis Fish technology, which has ability to test metaphase chromosomes from cultured samples and interphase cells from specimens that cannot be cultured.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- Abbott Laboratories
- Agilent Technologies Inc.
- ARUP Laboratories
- Asper Biogene
- ATS GENETECH PVT. LTD.
- Bio Rad Laboratories Inc.
- BioMerieux SA
- CENTOGENE NV
- Color Health Inc.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- Genea Ltd.
- Illumina Inc.
- Invitae Corp.
- MedGenome Labs Ltd.
- Myriad Genetics Inc.
- QIAGEN N.V.
- Quest Diagnostics Inc.
- Siemens Healthineers AG
- The Cooper Companies Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Research Analyst Overview
The market encompasses a range of technologies and applications, all focused on analyzing genetic information to inform healthcare and research. Microarray analysis, a technique that allows for the simultaneous measurement of thousands of genetic markers, plays a significant role in this domain. Clinical interpretation of the resulting data is a critical step in disease risk assessment and predictive testing. Genome sequencing, which involves determining the complete DNA sequence of an organism, is another essential technology in the market. It is used in various applications, including newborn screening, cancer genetics, and rare disease testing. Pharmaceutical companies also utilize genome sequencing for drug discovery and development.
Patient engagement is a crucial aspect of the market, with personalized nutrition and lifestyle genetics gaining popularity. Exome sequencing, which focuses on the protein-coding regions of the genome, is another advanced technology that offers more comprehensive genetic information. Genetic engineering, gene editing, and gene therapy are emerging areas of the market, holding significant potential for transforming healthcare. Clinical genetic testing services are increasingly being adopted by healthcare providers to improve patient care and outcomes. Data management and data analytics are essential components of the market, as the volume of genetic data generated continues to grow. Ethical considerations, including genetic privacy and data security, are also crucial in this domain.
The regulatory landscape for genetic testing is complex and evolving, with various regulatory bodies overseeing different aspects of the market. Consumer adoption of genetic testing is influenced by factors such as insurance coverage, consumer education, and the availability of genetic counseling. Next-generation sequencing (NGS) is a game-changer in the market, offering faster, more cost-effective, and more comprehensive genetic analysis. Liquid biopsy, which involves analyzing DNA and other genetic material found in bodily fluids, is another innovative technology gaining traction in the market. The market is diverse and dynamic, with various applications, technologies, and stakeholders. Market growth is driven by advances in technology, increasing awareness and acceptance of genetic testing, and the potential for personalized and precision medicine. Despite the challenges, the future of the market is promising, with significant opportunities for innovation and growth.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
239
|
|
Base year
|
2024
|
|
Historic period
|
2019-2023 |
|
Forecast period
|
2025-2029
|
|
Growth momentum & CAGR
|
Accelerate at a CAGR of 15.2%
|
|
Market growth 2025-2029
|
USD 11.05 Billion
|
|
Market structure
|
Fragmented
|
|
YoY growth 2024-2025(%)
|
12.9
|
|
Key countries
|
US, Germany, Canada, UK, France, China, Japan, Italy, India, and South Korea
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
What are the Key Data Covered in this Genetic Testing Market Research and Growth Report?
- CAGR of the Genetic Testing industry during the forecast period
- Detailed information on factors that will drive the growth and forecasting between 2025 and 2029
- Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
- Accurate predictions about upcoming growth and trends and changes in consumer behaviour
- Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
- Thorough analysis of the market’s competitive landscape and detailed information about companies
- Comprehensive analysis of factors that will challenge the genetic testing market growth of industry companies
We can help! Our analysts can customize this genetic testing market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Genetic Testing Market 2019 - 2023
- Historic Market Size - Data Table on Global Genetic Testing Market 2019 - 2023 ($ million)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
- 5.3 Technology segment analysis 2019 - 2023
- Historic Market Size - Technology Segment 2019 - 2023 ($ million)
- 5.4 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
- 5.5 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.6 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.7 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Genetic Testing Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
- 8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
- 8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 8.3 Equipment - Market size and forecast 2024-2029
- Chart on Equipment - Market size and forecast 2024-2029 ($ million)
- Data Table on Equipment - Market size and forecast 2024-2029 ($ million)
- Chart on Equipment - Year-over-year growth 2024-2029 (%)
- Data Table on Equipment - Year-over-year growth 2024-2029 (%)
- 8.4 Consumables - Market size and forecast 2024-2029
- Chart on Consumables - Market size and forecast 2024-2029 ($ million)
- Data Table on Consumables - Market size and forecast 2024-2029 ($ million)
- Chart on Consumables - Year-over-year growth 2024-2029 (%)
- Data Table on Consumables - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Technology
- 9.1 Market segments
- Chart on Technology - Market share 2024-2029 (%)
- Data Table on Technology - Market share 2024-2029 (%)
- 9.2 Comparison by Technology
- Chart on Comparison by Technology
- Data Table on Comparison by Technology
- 9.3 Molecular testing - Market size and forecast 2024-2029
- Chart on Molecular testing - Market size and forecast 2024-2029 ($ million)
- Data Table on Molecular testing - Market size and forecast 2024-2029 ($ million)
- Chart on Molecular testing - Year-over-year growth 2024-2029 (%)
- Data Table on Molecular testing - Year-over-year growth 2024-2029 (%)
- 9.4 Cytogenetic testing - Market size and forecast 2024-2029
- Chart on Cytogenetic testing - Market size and forecast 2024-2029 ($ million)
- Data Table on Cytogenetic testing - Market size and forecast 2024-2029 ($ million)
- Chart on Cytogenetic testing - Year-over-year growth 2024-2029 (%)
- Data Table on Cytogenetic testing - Year-over-year growth 2024-2029 (%)
- 9.5 Biochemical testing - Market size and forecast 2024-2029
- Chart on Biochemical testing - Market size and forecast 2024-2029 ($ million)
- Data Table on Biochemical testing - Market size and forecast 2024-2029 ($ million)
- Chart on Biochemical testing - Year-over-year growth 2024-2029 (%)
- Data Table on Biochemical testing - Year-over-year growth 2024-2029 (%)
- 9.6 Market opportunity by Technology
- Market opportunity by Technology ($ million)
- Data Table on Market opportunity by Technology ($ million)
10 Market Segmentation by Application
- 10.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
- 10.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 10.3 Cancer diagnosis - Market size and forecast 2024-2029
- Chart on Cancer diagnosis - Market size and forecast 2024-2029 ($ million)
- Data Table on Cancer diagnosis - Market size and forecast 2024-2029 ($ million)
- Chart on Cancer diagnosis - Year-over-year growth 2024-2029 (%)
- Data Table on Cancer diagnosis - Year-over-year growth 2024-2029 (%)
- 10.4 Genetic disease diagnosis - Market size and forecast 2024-2029
- Chart on Genetic disease diagnosis - Market size and forecast 2024-2029 ($ million)
- Data Table on Genetic disease diagnosis - Market size and forecast 2024-2029 ($ million)
- Chart on Genetic disease diagnosis - Year-over-year growth 2024-2029 (%)
- Data Table on Genetic disease diagnosis - Year-over-year growth 2024-2029 (%)
- 10.5 Cardiovascular disease diagnosis - Market size and forecast 2024-2029
- Chart on Cardiovascular disease diagnosis - Market size and forecast 2024-2029 ($ million)
- Data Table on Cardiovascular disease diagnosis - Market size and forecast 2024-2029 ($ million)
- Chart on Cardiovascular disease diagnosis - Year-over-year growth 2024-2029 (%)
- Data Table on Cardiovascular disease diagnosis - Year-over-year growth 2024-2029 (%)
- 10.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 10.7 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
11 Market Segmentation by End-user
- 11.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 11.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 11.3 Hospitals and clinics - Market size and forecast 2024-2029
- Chart on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals and clinics - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals and clinics - Year-over-year growth 2024-2029 (%)
- 11.4 Diagnostic laboratories and centres - Market size and forecast 2024-2029
- Chart on Diagnostic laboratories and centres - Market size and forecast 2024-2029 ($ million)
- Data Table on Diagnostic laboratories and centres - Market size and forecast 2024-2029 ($ million)
- Chart on Diagnostic laboratories and centres - Year-over-year growth 2024-2029 (%)
- Data Table on Diagnostic laboratories and centres - Year-over-year growth 2024-2029 (%)
- 11.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 11.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
12 Customer Landscape
- 12.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
13 Geographic Landscape
- 13.1 Geographic segmentation
- Chart on Market share by geography 2024-2029 (%)
- Data Table on Market share by geography 2024-2029 (%)
- 13.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 13.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 13.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 13.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 13.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 13.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 13.9 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 13.10 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 13.11 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 13.12 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 13.13 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 13.14 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ million)
- Data Table on Italy - Market size and forecast 2024-2029 ($ million)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
- 13.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 13.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 13.17 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
14 Drivers, Challenges, and Opportunity/Restraints
- 14.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 14.4 Market opportunities/restraints
15 Competitive Landscape
- 15.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 15.3 Landscape disruption
- Overview on factors of disruption
- 15.4 Industry risks
- Impact of key risks on business
16 Competitive Analysis
- 16.2 Company ranking index
- 16.3 Market positioning of companies
- Matrix on companies position and classification
- 16.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
- 16.5 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 16.6 ATS GENETECH PVT. LTD.
- ATS GENETECH PVT. LTD. - Overview
- ATS GENETECH PVT. LTD. - Product / Service
- ATS GENETECH PVT. LTD. - Key offerings
- SWOT
- 16.7 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 16.8 BioMerieux SA
- BioMerieux SA - Overview
- BioMerieux SA - Business segments
- BioMerieux SA - Key news
- BioMerieux SA - Key offerings
- BioMerieux SA - Segment focus
- SWOT
- 16.9 Color Health Inc.
- Color Health Inc. - Overview
- Color Health Inc. - Product / Service
- Color Health Inc. - Key offerings
- SWOT
- 16.10 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 16.11 Genea Ltd.
- Genea Ltd. - Overview
- Genea Ltd. - Product / Service
- Genea Ltd. - Key offerings
- SWOT
- 16.12 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
- 16.13 Invitae Corp.
- Invitae Corp. - Overview
- Invitae Corp. - Product / Service
- Invitae Corp. - Key offerings
- SWOT
- 16.14 Myriad Genetics Inc.
- Myriad Genetics Inc. - Overview
- Myriad Genetics Inc. - Product / Service
- Myriad Genetics Inc. - Key news
- Myriad Genetics Inc. - Key offerings
- SWOT
- 16.15 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key news
- QIAGEN N.V. - Key offerings
- SWOT
- 16.16 Quest Diagnostics Inc.
- Quest Diagnostics Inc. - Overview
- Quest Diagnostics Inc. - Business segments
- Quest Diagnostics Inc. - Key offerings
- Quest Diagnostics Inc. - Segment focus
- SWOT
- 16.17 Siemens Healthineers AG
- Siemens Healthineers AG - Overview
- Siemens Healthineers AG - Business segments
- Siemens Healthineers AG - Key news
- Siemens Healthineers AG - Key offerings
- Siemens Healthineers AG - Segment focus
- SWOT
- 16.18 The Cooper Companies Inc.
- The Cooper Companies Inc. - Overview
- The Cooper Companies Inc. - Business segments
- The Cooper Companies Inc. - Key news
- The Cooper Companies Inc. - Key offerings
- The Cooper Companies Inc. - Segment focus
- SWOT
17 Appendix
- 17.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 17.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 17.4 Research methodology
- 17.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 17.9 360 degree market analysis
- 360 degree market analysis
- 17.10 List of abbreviations
INFORMATION SOURCES
DATA ANALYSIS
REPORT WRITING
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
